Literature DB >> 8611466

Cytokine levels in platelet concentrates: quantitation by bioassays and immunoassays.

M Wadhwa1, M J Seghatchian, A Lubenko, M Contreras, P Dilger, C Bird, R Thorpe.   

Abstract

Some adverse reactions to the transfusion of platelet concentrates (PCs) cannot be attributed to antibodies against blood cells or to subclinical microbial agents. It has been suggested that leucocyte-derived inflammatory cytokines such as interleukin (IL)-1, IL-6 and tumour necrosis factor (TNF) may contribute to a larger number of unexplained non-antibody-mediated adverse reactions. Three types of PCs, containing different levels of leucocytes, are currently produced. Filtration is used on demand to further reduce leucocyte contamination of these components. we have monitored the plasma of PCs prepared by the platelet-rich plasma method (PRP), the buffy-coat method or by apheresis for IL-6, IL-1, transforming growth factor-beta (TGF-beta), TNF and interferon gamma (IFN gamma). Biologically active IL-6 increased in stored PRP-PCs from a mean of 140 pg/ml on day 1 to 2395 pg/ml on day 5/6. Elevated levels of IL-8, as detected by immunoassay, were evident in PRP-PCs during routine storage under blood bank conditions. Small amounts of immunoreactive IL-1 with only minimal biological activity were present in some PRP-PCs by day 5/6. No significant increase in the levels of IL-8, IL-6 or IL-1 were seen in buffy-coat PCs during storage for 5/6 d. For apheresis PCs, an increase in IL-8 content, but not in IL-6 over 6 d was observed. In all three types of PCs, elevated amounts of both bioactive and immunoreactive TGF beta were present, but there was no evidence of any biologically active or immunoreactive TNF alpha. Pre-storage filtration of PRP-PCs for depletion of leucocytes prevented the increase in IL-8 and IL-6 levels of these PCs. Our results show that leucocyte reduction by buffy-coat method reduces cytokine levels to a comparable level to filtered or apheresis PCs, containing low levels of leucocytes, but use of these PCs in minimizing the severity and incidence of reactions in recipients will require clinical evaluation. This is the first comprehensive and comparative study which, on the basis of biological activity of cytokines, directly indicates that the mode of platelet production grossly influences the levels of cytokines.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8611466     DOI: 10.1046/j.1365-2141.1996.4611002.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


  12 in total

1.  The IgE-dependent pathway in allergic transfusion reactions: involvement of donor blood allergens other than plasma proteins.

Authors:  Nobuki Matsuyama; Kazuta Yasui; Etsuko Amakishi; Tomoya Hayashi; Ayumu Kuroishi; Hiroyuki Ishii; Harumichi Matsukura; Yoshihiko Tani; Rika A Furuta; Fumiya Hirayama
Journal:  Int J Hematol       Date:  2015-04-04       Impact factor: 2.490

2.  Determining the Effect of Preparation and Storage: An Effort to Streamline Platelet Components as a Source of Growth Factors for Clinical Application.

Authors:  Atul Sonker; Anju Dubey
Journal:  Transfus Med Hemother       Date:  2015-01-29       Impact factor: 3.747

Review 3.  Platelet Derived Biomaterials for Therapeutic Use: Review of Technical Aspects.

Authors:  Satyam Arora; Naveen Agnihotri
Journal:  Indian J Hematol Blood Transfus       Date:  2016-03-29       Impact factor: 0.900

4.  Pilot analysis of cytokines levels in stored granulocyte-colony-stimulating factor-mobilized peripheral blood stem cell concentrates.

Authors:  Iyonna Woods; Abdul Tawab-Amiri; Karen Byrne; Marianna Sabatino; David F Stroncek
Journal:  Transfusion       Date:  2010-09       Impact factor: 3.157

5.  Studies on the biological effects of ozone: 10. Release of factors from ozonated human platelets.

Authors:  G Valacchi; V Bocci
Journal:  Mediators Inflamm       Date:  1999       Impact factor: 4.711

6.  A randomized trial of washed red blood cell and platelet transfusions in adult acute leukemia [ISRCTN76536440].

Authors:  Neil Blumberg; Joanna M Heal; Jacob M Rowe
Journal:  BMC Blood Disord       Date:  2004-12-10

7.  Defining an appropriate leucoreduction strategy by serial assessment of cytokine levels in platelet concentrates prepared by different methods.

Authors:  Daljit Kaur; Ratti Ram Sharma; Neelam Marwaha
Journal:  Asian J Transfus Sci       Date:  2015 Jan-Jun

Review 8.  Current understanding of allergic transfusion reactions: incidence, pathogenesis, laboratory tests, prevention and treatment.

Authors:  Fumiya Hirayama
Journal:  Br J Haematol       Date:  2012-12-06       Impact factor: 6.998

9.  Problems in early diagnosis of bladder cancer in a spinal cord injury patient: report of a case of simultaneous production of granulocyte colony stimulating factor and parathyroid hormone-related protein by squamous cell carcinoma of urinary bladder.

Authors:  Subramanian Vaidyanathan; Paul Mansour; Munehisa Ueno; Kazuto Yamazaki; Meenu Wadhwa; Bakul M Soni; Gurpreet Singh; Peter L Hughes; Ian D Watson; Pradipkumar Sett
Journal:  BMC Urol       Date:  2002-08-30       Impact factor: 2.264

Review 10.  Cell-Based Therapies for Joint Disease in Veterinary Medicine: What We Have Learned and What We Need to Know.

Authors:  Sophie Helen Bogers
Journal:  Front Vet Sci       Date:  2018-04-16
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.